Skip to main content

Market Overview

Pieris Pharmaceuticals, Inc. (PIRS)

3.53 -0.27 (-7.11%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-0.26
2.939M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.07
13.261M
-0.17
6.47M
-0.07
15.633M
58.82%
141.62%
Q4 2020
Pre-Market
EPS:
REV:
-0.06
17.27M
-0.24
3.82M
-0.26
1.877M
-8.33%
-50.86%
Q3 2020
Pre-Market
EPS:
REV:
-0.05
15.132M
-0.13
9.79M
-0.26
2.939M
-100%
-69.98%
Q2 2020
Pre-Market
EPS:
REV:
-0.24
5.332M
-0.17
7.76M
-0.09
11.246M
47.06%
44.92%
Q1 2020
Pre-Market
EPS:
REV:
-0.20
8.545M
-0.17
8.84M
-0.07
13.261M
58.82%
50.01%
Q4 2019
Pre-Market
EPS:
REV:
-0.21
4.914M
-0.28
4.82M
-0.06
17.27M
78.57%
258.3%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!